About US
Contact us
-
Pfizer plans to shell out a stunning $14B for Medivation. Will the bet pay off?The Medivation hunt is over. Pfizer has struck a deal to buy the California-based biotech for a whopping $14 billion. The next question is this: Will the buy deliver much payoff for the drug giant? O2016/9/13
-
NICE backs Pfizer's Xalkori after squeezing out a new discountWhile many of itspeers have publicly attacked England’s price watchdog NICE in recent weeks, Pfizer ($PFE) is on a bit of a hot streak. In itssecond recommendationin as many months, the company won ba2016/9/12
-
Merck joins Pfizer, Sanofi in high-stakes hunt for MedivationMerck & Co. wants Medivation, too. Not content to let another Big Pharma snap up the cancer-focused biotech unchallenged, Merck has joined the fight for a prize valued at more than $10 billion. R2016/9/12
-
M&As this week: Allergan, Asahi GlassPharmaceutical companyAllerganhas acquired all assets of biotechnology company RetroSense Therapeutics through an all-cash transaction worth $60m. "The acquisition enables Allergan to further advance2016/9/9
-
Report: Philippines pharmaceutical market to grow at CAGR of 3.7% to reach $4.1bn by 2020The Philippines pharmaceutical market is projected to rise moderately from $3.4bn in 2015 to $4.1bn by 2020 at a compound annual growth rate of 3.7%, according to a new report by GlobalData. Titled '2016/9/9
-
New research discovers compounds with potential to prevent transmission of malariaResearchers at the Broad Institute of MIT and Harvard have discovered compounds with potential to prevent thetransmission of malaria. The new compounds act on a novel target in the malaria parasite,2016/9/8
-
US firm twoXAR and Stanford University partner to identify drug candidates for HCCUS-based twoXAR has collaborated with Stanford University School of Medicine’s Asian Liver Centre, in a bid to support research for identifying drug candidates targeting hepatocellular carcinoma (HCC)2016/9/8
-
Sun Pharma forms distribution partnership with Mitsubishi Tanabe in JapanSun Pharma has formed a distribution partnership with Mitsubishi Tanabe Pharma Corporation in Japan for the 14prescription brands acquired from Novartis. The movemarks the initiation of a phased tran2016/9/7
-
Takeda to develop vaccine to support Zika response in USThe US Biomedical Advanced Research and Development Authority (BARDA) has selected Japanese company Takeda Pharmaceutical’s Vaccine Business Unit to develop a vaccine to support the Zika response with2016/9/7
-
Biogen’s investigational treatment Aducanumab secures FDA fast-track designationBiogen’s investigational treatment Aducanumab for early Alzheimer’s disease (AD) has secured fast-track designation from the US Food and Drug Administration (FDA). The programme will support the deve2016/9/6